A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Ethacrynic Acid (EDECRIN)

Ethacrynic Acid removes excess fluid by acting on the kidneys, used in heart failure and edema.

First FDA approval1967-01-10
Generic availableYes · 7 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$9.3M in CY2024 Part D spend23K claims · 7K beneficiaries · 329 plans surveyed

Lowest NADAC
$0.816/unit
5 NDCs benchmarked, lowest of all strengths.
Average NADAC
$0.816
Across all dosage forms in distribution.
Highest NADAC
$0.816
Range is tight.
Plans with PA
2 / 329
Limited PA friction.

Questions a plan sponsor actually asks.

FAQPage schema11 entries indexed · 4 visible
What is Ethacrynic Acid used for?

Ethacrynic Acid removes excess fluid by acting on the kidneys, used in heart failure and edema.

Is there a generic for Ethacrynic Acid?

Yes. 7 ANDAs filed at FDA, 7 generic manufacturers currently shipping.

How much does my plan pay for Ethacrynic Acid?

Across 329 Part D plans, Ethacrynic Acid averages $0.816/unit (NADAC). Lowest available: $0.816/unit. Highest in distribution: $0.816/unit.

Is Ethacrynic Acid on the FDA shortage list?

No. Ethacrynic Acid is not currently on the FDA Drug Shortage Database.

7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Loop Diuretic4 alternatives in D1
01
Bumetanide
Brand: Bumex
$0.115Lowest NADAC
19Generic mfrs
$116.6MCY24 Part D spend
Compare →
02
Furosemide
Brand: LASIX ONYU
$0.027Lowest NADAC
21Generic mfrs
$231.6MCY24 Part D spend
Compare →
03
Furosemide Injection
Brand: FUROSCIX
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
04
Torsemide
Brand: SOAANZ
$0.063Lowest NADAC
6Generic mfrs
$90.6MCY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (8 approvals on file) · NADAC unit costs: CMS NADAC weekly file (5 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.